Correlation Between NewAmsterdam Pharma and NewAmsterdam Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and NewAmsterdam Pharma, you can compare the effects of market volatilities on NewAmsterdam Pharma and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and NewAmsterdam Pharma.

Diversification Opportunities for NewAmsterdam Pharma and NewAmsterdam Pharma

0.97
  Correlation Coefficient

Almost no diversification

The 3 months correlation between NewAmsterdam and NewAmsterdam is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and NewAmsterdam Pharma go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and NewAmsterdam Pharma

Assuming the 90 days horizon NewAmsterdam Pharma is expected to generate 1.83 times more return on investment than NewAmsterdam Pharma. However, NewAmsterdam Pharma is 1.83 times more volatile than NewAmsterdam Pharma. It trades about 0.05 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.08 per unit of risk. If you would invest  890.00  in NewAmsterdam Pharma on August 25, 2024 and sell it today you would earn a total of  0.00  from holding NewAmsterdam Pharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy95.65%
ValuesDaily Returns

NewAmsterdam Pharma  vs.  NewAmsterdam Pharma

 Performance 
       Timeline  
NewAmsterdam Pharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, NewAmsterdam Pharma showed solid returns over the last few months and may actually be approaching a breakup point.
NewAmsterdam Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, NewAmsterdam Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

NewAmsterdam Pharma and NewAmsterdam Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NewAmsterdam Pharma and NewAmsterdam Pharma

The main advantage of trading using opposite NewAmsterdam Pharma and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.
The idea behind NewAmsterdam Pharma and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities